Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Inhibrx Biosciences (INBX) Other Non Operating Income: 2023-2024

Historic Other Non Operating Income for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $75,000.

  • Inhibrx Biosciences' Other Non Operating Income fell 212.20% to -$46,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$282,000, marking a year-over-year decrease of 97.20%. This contributed to the annual value of $75,000 for FY2024, which is 112.93% up from last year.
  • As of FY2024, Inhibrx Biosciences' Other Non Operating Income stood at $75,000, which was up 112.93% from -$580,000 recorded in FY2023.
  • Over the past 5 years, Inhibrx Biosciences' Other Non Operating Income peaked at $75,000 during FY2024, and registered a low of -$580,000 during FY2023.
  • For the 2-year period, Inhibrx Biosciences' Other Non Operating Income averaged around -$252,500, with its median value being -$252,500 (2023).
  • Data for Inhibrx Biosciences' Other Non Operating Income shows a peak YoY skyrocketed of 112.93% (in 2024) over the last 5 years.
  • Over the past 2 years, Inhibrx Biosciences' Other Non Operating Income (Yearly) stood at -$580,000 in 2023, then skyrocketed by 112.93% to $75,000 in 2024.